1 – 100 of 120
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Microbiome alterations in pancreatic cancer : new insights and potential clinical implications
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–one key to early detection of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anoikis-related genes linked with patient outcome in pancreatic cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
-
Mark
Histopathological investigation of colon liver metastases–which factors affect survival after surgery?
(
- Contribution to journal › Article
- 2022
-
Mark
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
- 2021
-
Mark
Surgical Infections and Antibiotic Stewardship : In Need for New Directions
(
- Contribution to journal › Article
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IPMN of the pancreas–does histological subtyping allow for improved stratification and follow-up?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–can evidence-based guidelines be transferred to an optimized comprehensive treatment program?
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Re-resection for incidentally detected gallbladder cancer : Weighing in on the options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Dilemma of Drains after Pancreatoduodenectomy : Still an Issue?
(
- Contribution to journal › Article
-
Mark
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
(
- Contribution to journal › Article
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
-
Mark
Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas–what’s beyond the horizon?
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Sustainability of an Enhanced Recovery Program for Pancreaticoduodenectomy with Pancreaticogastrostomy
(
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of duodenal perforations : a narrative review
(
- Contribution to journal › Scientific review
-
Mark
Early postoperative fluid retention is a strong predictor for complications after pancreatoduodenectomy
(
- Contribution to journal › Article
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
(
- Contribution to journal › Article
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer
(
- Contribution to journal › Scientific review
-
Mark
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Intraductal Papillary Mucinous Neoplasms of the Pancreas : A Nationwide Registry-Based Study
(
- Contribution to journal › Article
-
Mark
Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
-
Mark
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Primary lymph node ratio and hepatic resection for colorectal metastases
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review
-
Mark
Thymidylate synthase : A predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment
(
- Contribution to journal › Article
-
Mark
Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases
(
- Contribution to journal › Article
- 2017
-
Mark
Hemorrhage after Major Pancreatic Resection: Incidence, Risk Factors, Management, and Outcome.
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Postoperative pancreatic fistula-impact on outcome, hospital cost and effects of centralization
(
- Contribution to journal › Article
-
Mark
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer : a two-center retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Acute biliary pancreatitis: focus on recurrence rate and costs when current guidelines are not complied
(
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous neoplasm of the pancreas–epidemiology, risk factors, diagnosis, and management
(
- Contribution to journal › Scientific review
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic ductal adenocarcinoma : Is a cure possible?
(
- Contribution to journal › Scientific review
-
Mark
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms : Relevant for decision making?
(
- Contribution to journal › Scientific review
-
Mark
Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?
(
- Contribution to journal › Scientific review
-
Mark
Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
The challenges of centralization with HPB resectional surgery
(
- Contribution to journal › Letter
-
Mark
Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
- 2016
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Yesterday, today and tomorrow
(
- Contribution to journal › Article
-
Mark
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
(
- Contribution to journal › Article
-
Mark
Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases
(
- Contribution to journal › Article
-
Mark
Immune checkpoint therapy for pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Safety of pancreatic resection in the elderly : a retrospective analysis of 556 patients
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of histone related modifications of formaldehyde fixed paraffin embedded and fresh frozen pancreatic tumor xenografts using LC-MS/MS
(
- Contribution to journal › Article
- 2015
-
Mark
Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature.
(
- Contribution to journal › Article
-
Mark
Severe Acute Pancreatitis: Gut Barrier Failure, Systemic Inflammatory Response, Acute Lung Injury, and the Role of the Mesenteric Lymph.
(
- Contribution to journal › Scientific review
-
Mark
SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer.
(
- Contribution to journal › Article
-
Mark
In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment.
(
- Contribution to journal › Article
-
Mark
The role of SPARC expression in pancreatic cancer progression and patient survival.
(
- Contribution to journal › Article
-
Mark
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Update on the management of pancreatic cancer: Surgery is not enough.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Radioimmunotherapy-a potential novel tool for pancreatic cancer therapy?
(
- Contribution to journal › Scientific review
-
Mark
Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study.
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic Cancer - Early Detection, Prognostic Factors, and Treatment
(
- Thesis › Doctoral thesis (compilation)
-
Mark
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review.
(
- Contribution to journal › Article
-
Mark
Analysis of MUC4 Expression in Human Pancreatic Cancer Xenografts in Immunodeficient Mice.
(
- Contribution to journal › Article
-
Mark
Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.
(
- Contribution to journal › Article
-
Mark
Neoadjuvant/Downstaging Radiochemotherapy in Marginally Resectable Pancreatic Cancer
(
- Contribution to journal › Article
-
Mark
Pancreaticoduodenectomy - the transition from a low- to a high-volume center.
(
- Contribution to journal › Article
- 2013
-
Mark
Portal Venous System Thrombosis After Pancreatic Resection
(
- Contribution to journal › Article
-
Mark
Surgical stress response after colorectal resection.
(
- Contribution to journal › Article